Endocrine Metabolic Consortium Overview (Nov 2013)

As part of GPC-USA, the Endocrine-Metabolic Consortium will develop methodological standards for patient-centered outcomes research and comparative effectiveness research in endocrine and metabolic diseases.

The Consortium is composed of a diverse group of experts and stakeholders representing patients and consumers, the life sciences industry, payers and purchasers, health systems and care providers, researchers, research funders, regulators, and health professional organizations.  With general oversight from GPC-USA’s Advisory Committee, Consortium members participate in the development of methodological standards which are then issued as Effectiveness Guidance Documents (EGDs).